The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Assessing the impact of attrition in randomized controlled trials
Abstract
Objectives A survey of randomized controlled trials found that almost a quarter of trials had more than 10% of responses missing for the primary outcome. There are a number of ways in which data could be missing: the subject is unable to provide it, or they withdraw, or become lost to follow-up. Such attrition means that balance in baseline characteristics for those randomized may not be maintained in the subsample who has outcome data. For individual trials, if the attrition is systematic and linked to outcome, then this will result in biased estimates of the overall effect. It then follows that if such trials are combined in a meta-analysis, it will result in a biased estimate of the overall effect and be misleading. The aim of this study was to investigate the impact of attrition on baseline imbalance within individual trials and across multiple trials.Study design and setting In this article, we used individual patient data from a convenience sample of 10 trials evaluating interventions for the treatment of musculoskeletal disorders. Meta-analyses using the mean difference at baseline between the trial arms were carried out using individual patient data from these trials. The analyses were first carried out using all randomized participants and secondly only including participants with outcome data on the quality-of-life score. Meta-regression was carried out to evaluate whether the level of baseline imbalance was associated with the level of attrition.Results The overall attrition rates for the quality-of-life score ranged between 4% and 28% of the total randomized patients. All trials showed some level of differential attrition between the treatment arms, ranging from 1% to 14%. Attrition within the control group ranged from 3% to 25% and within the intervention group, it ranged from 0% to 31%. For individual trials, there was no indication that attrition altered the results in favor of either the treatment or the control. Forest plots highlighted that the attrition had some impact on the baseline imbalance for the primary outcome score as more heterogeneity was introduced (I-squared value of 0.4% for the initial data set vs. I-squared value of 16.9% for the analyzed data set). However, the standardized mean difference increased only slightly (from 0.01 to 0.03 with 95% confidence interval [CI]: -0.05, 0.10). Meta-regression showed little or no evidence of a significant dose-response relationship between the level of attrition and the baseline imbalance (coefficient 0.73, 95% CI: -0.81, 2.28).Conclusion Although, in theory, attrition can introduce selection bias in randomized trials, we did not find sufficient evidence to support this claim in our convenience sample of trials. However, the number of trials included was relatively small, which may have led to small but important differences in outcomes being missed. In addition, only 2 of 10 trials included had attrition levels greater than 15% suggesting a low level of potential bias. Meta-analyses and systematic reviews should always consider the impact of attrition on baseline imbalances and where possible any baseline imbalances in the analyzed data set and their impact on the outcomes reported.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inadequate allocation concealment can lead to overestimation or underestimation of treatment effects [64], while attrition bias could skew results, thereby affecting our overall judgement of the effectiveness of ACT [65].”
From Acceptance and commitment therapy for patients with chronic pain: A systematic review and meta-analysis on psychological outcomes and quality of life (2024) · cites this paper as [65]
In the citing paper
“Rates of completion for behavioral medicine trials for nonveterans have been reported as ranging from 41% to 90%66 and 50% to 63% for psychopharmacology67 trials and 63% to 100% for other randomized controlled trials.68”
From Treatment Engagement and Outcomes of Mindfulness-Based Cognitive Therapy for Veterans with Psychiatric Disorders (2019) · cites this paper as [68]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Review: a gentle introduction to imputation of missing values.
Donders, A. R. T., van der Heijden, G. J. M. G., Stijnen, T., & Moons, K. G. M. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.01.014 · Cited by 2,582
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Sample size slippages in randomised trials: exclusions and the lost and wayward.
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07882-0 · Cited by 642
UK BEAM Trial Team (2004) · BMJ · doi:10.1136/bmj.38282.669225.ae · Cited by 515
Cited by
Sorted by citations
Items 101–139 of 139
Recruitment and retention interventions in surgical and wound care trials: A systematic review
Arundel, C., & Mott, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288028 · Cited by 2
Arundel, C., Welch, C., Tharmanathan, P., & Dias, J. J. (2024) · Research Methods in Medicine & Health Sciences · doi:10.1177/26320843241229934 · Cited by 2
High, J., Grant, K., Hope, A., Shepstone, L., West, C., Colles, A., & Naughton, F. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae068 · Cited by 2
Keemink, J. R., Stander, W. J., Montgomery, P., & Schaub, J. (2025) · Social Work Research · doi:10.1093/swr/svaf002 · Cited by 2
Donohue, C., Carnaby, G., & Garand, K. L. (2022) · American Journal of Speech-Language Pathology · doi:10.1044/2021_ajslp-21-00267 · Cited by 2
Blampied, M., Bell, C., Gilbert, C., Boden, J. M., Nicholls, R. J., & Rucklidge, J. J. (2018) · Medicines · doi:10.3390/medicines5020056 · Cited by 2
Controlling Bias in Randomized Clinical Trials
BARTON, B. A. (2022) · Springer eBooks · doi:10.1007/978-3-319-52636-2_214 · Cited by 2
Newman, C., Adriaens, E., Virgilio, N., Vleminckx, S., Pelsmaeker, S. D., Prawitt, J., & Silva, C. I. F. (2023) · JMIR Formative Research · doi:10.2196/42967 · Cited by 2
Koutentakis, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-91790-2.00054-x · Cited by 1
Effectiveness of a salivary progesterone-based fertility awareness contraceptive method
Adornetto, G., Caglio, G., Whitehouse, K., Dolati, S., Dax, A., Wedemeyer, R., Warnke, A., Rautenberg, T., & Rapti, E. (2025) · Contraception · doi:10.1016/j.contraception.2025.111304 · Cited by 1
Dong, Y., & Roberts, G. J. (2026) · Journal of Research on Educational Effectiveness · doi:10.1080/19345747.2026.2634037 · Cited by 1
Plaskan, K., Vodičar, M., & Pajek, M. (2026) · Applied Sciences · doi:10.3390/app16104695 · Cited by 1
Dwivedi, A. K., Imbimbo, B. P., Abanto, J. T., & Espay, A. J. (2026) · BMJ Neurology Open · doi:10.1136/bmjno-2026-001649 · Cited by 1
Parkman, C. A. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/4798024 · Cited by 1
Arundel, C., Zahra, S., Chetter, I. C., on behalf of the SWHSI-2 Trial Investigators, Baird, K., Martin, B. C., Hewitt, C., Fairhurst, C., Gkekas, A., Mott, A., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01658-w · Cited by 1
Self-citationTong, F., Irby, B. J., Lara‐Alecio, R., Guerrero, C. L., Tang, S., Sutton‐Jones, K. L., & Ross, S. M. (2023) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2023.102262 · Cited by 1
Retrospective analysis of a South African cardiovascular trial site’s patient retention rates
Burgess, L. J. (2010) · Open Access Journal of Clinical Trials · doi:10.2147/oajct.s13896 · Cited by 1
Prevention of long-term sickness absence and major depression through early intervention
Lexis, M. A. S. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110520ml
Ng, S., Byrnes, J., & Scuffham, P. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.07.013
Assessment of the Risk of Bias
Moon, K., & Rao, S. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-71921-0_4
Gnambs, T., & Schroeders, U. (2022) · doi:10.31234/osf.io/hte6z
Evaluations Amid Measurement Error: Determining the Optimal Timing for Workplace InterventionsPreprint
DiSorbo, M. D., Bojinov, I., & Menchetti, F. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4863206
Lo, S., Chuang, S., & Yang, C.-C. (2024) · Journal of Tissue Viability · doi:10.1016/j.jtv.2024.12.013
Masuluke Irene, M., Kolkenbeck‐Ruh, A., Mutabazi, J. C., Zarowsky, C., Norris, S. A., Levitt, N. S., & Ware, L. J. (2025) · Reproductive Female and Child Health · doi:10.1002/rfc2.70038
Salehian, S., Sharafi, S., Nasiri, A., & Bady, S. A. M. (2025) · Journal of Translational Medical Research · doi:10.61882/jbums.32.2.141
Côté, P., Hartvigsen, J., Axén, I., Leboeuf-Yde, C., Corso, M., Shearer, H., Wong, J., Marchand, A.-A., Cassidy, J. D., French, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14053675
Shi, Z., Hu, B., Lu, M., Chen, Z., Zhang, M., Yu, Y., Zhou, C., Zhong, J., Wu, B., Zhang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26729638
Shi, Z., Hu, B., Lu, M., Chen, Z., Zhang, M., Yu, Y., Zhou, C., Zhong, J., Wu, B., Zhang, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26729635
Tang, V. F. Y., Jiang, D., Kwok, J. Y. Y., Ho, H. C. Y., Jian, I. Y., Choi, N. G., Cruwys, T., You, J., Warner, L. M., Seewer, N., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1741422
Hanna, L., Burns, C., Neill, C. O., & Coughlan, E. K. (2026) · Future · doi:10.3390/future4010011
Parkes, D., Boos, D. D., & Cogger-Ward, H. (2026) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2026.100612
Malki, H. E., Moutawakkil, S. G., El‐Ammari, A., Ragala, M. E. A., Taoufik, F., Gnaoui, S. E., Zaidi, K., TAOUFIQ, P. D. I., Chibri, S., Beniaich, G., et al. (2026) · Addiction Science & Clinical Practice · doi:10.1186/s13722-026-00691-1
Statistics of Randomized Clinical Trials
Nguyen, T., Liu, C., Ni, L., & Xie, R. (2026) · Springer eBooks · doi:10.1007/978-3-032-19175-5_11
Data Analysis Planning and Reporting for Confirmatory Multi‐Lab Preclinical Trials: A Tutorial
Arroyo-Araujo, M., Carneiro, C. F. D., Piper, S. K., Wilcke, J. C., Ellenbach, N., Boulesteix, A., Emprechtinger, R., Ineichen, B. V., Riecken, L. B., Haller, B., et al. (2026) · Biometrical Journal · doi:10.1002/bimj.70152
Avinç, E. (2026) · Sustainable Development · doi:10.1002/sd.71687
Öcalan, S., Üzar‐Özçetin, Y. S., Dızdar, Ö., & Gürel, Ş. C. (2026) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2026.103355
Translational studies to evaluate plaque control interventions
Stone, S. J. (2013)
Metadata
- Authors
- Hewitt, C. E., Kumaravel, B., Dumville, J. C., & Torgerson, D. J.
- Affiliations
- University of York (GB)
- Corresponding author
- Hewitt, Catherine E.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 63
- Issue
- 11
- Pages
- 1264-1270
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2005371124
- Cited by
- 139
- References
- 28
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 15 · 2023: 11 · 2022: 8 · 2021: 13 · 2020: 14 · 2019: 8 · 2018: 6 · 2017: 4 · 2016: 6 · 2015: 10 · 2014: 7 · 2013: 7 · 2012: 3
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
- Keywords
- attrition, loss to follow-up, baseline imbalance, differential attrition, missing data, meta-analysis bias, individual patient data, musculoskeletal disorders, quality of life, heterogeneity, attrition rates
- MeSH terms
- Data Collection, Humans, Musculoskeletal Diseases, Patient Dropouts, Meta-Analysis as Topic, Bias, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review